Difference between revisions of "Team:BNU-China/Engagement-PUMCH"

Line 28: Line 28:
 
             <p>Q: Do you think there would be improvement in taxol treatment?</p>
 
             <p>Q: Do you think there would be improvement in taxol treatment?</p>
 
             <p>A: People will tend to use targeted drugs and immunologic therapy in the future. And now many cancer have their own targeted drugs. But for most patients, they can’t afford it and can’t check his or her target. In these cases, we still choose traditional treatment. So maybe traditional therapy would be obsolete in some day, but won’t be substitued soon.</p>
 
             <p>A: People will tend to use targeted drugs and immunologic therapy in the future. And now many cancer have their own targeted drugs. But for most patients, they can’t afford it and can’t check his or her target. In these cases, we still choose traditional treatment. So maybe traditional therapy would be obsolete in some day, but won’t be substitued soon.</p>
                
+
               <p>jidjfa; fda;i <p>asjfhua huiahfb aiab ifhadsui</p>aafa vad afefas</p>
 
       </html>
 
       </html>

Revision as of 17:42, 18 October 2016

Team:BNU-CHINA - 2016.igem.org

HUMAN PRACTICE